PE20011270A1 - [5-ciclopropil-1-(2-quinolon-5-il)-1h-pirazol-4-carbonil]guanidina como inhibidor del intercambiador de sodio-hidrogeno de tipo 1 (nhe-1) - Google Patents
[5-ciclopropil-1-(2-quinolon-5-il)-1h-pirazol-4-carbonil]guanidina como inhibidor del intercambiador de sodio-hidrogeno de tipo 1 (nhe-1)Info
- Publication number
- PE20011270A1 PE20011270A1 PE2001000376A PE2001000376A PE20011270A1 PE 20011270 A1 PE20011270 A1 PE 20011270A1 PE 2001000376 A PE2001000376 A PE 2001000376A PE 2001000376 A PE2001000376 A PE 2001000376A PE 20011270 A1 PE20011270 A1 PE 20011270A1
- Authority
- PE
- Peru
- Prior art keywords
- quinolon
- guanidine
- carbonyl
- cyclopropil
- pirazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Treatment Of Water By Ion Exchange (AREA)
- Preventing Corrosion Or Incrustation Of Metals (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I [5-CICLOPROPIL-1-(2-QUINOLON-5-IL)-1H-PIRAZOL-4-CARBONIL]GUANIDINA CON LA CONDICION DE QUE EL COMPUESTO [5-CICLOPROPIL-1-(QUINOLON-5-IL)-1H-PIRAZOL-4-CARBONIL]GUANIDINA NO SE INCLUYA. LA DOSIS ES DE 0,01mg/kg/DIA A 50 mg/kg/DIA Y SE ADMINISTRA DE MODO PROFILACTICO, ANTES O DURANTE LA CIRUGIA Y EN LAS 24 HORAS SIGUIENTES A LA CIRUGIA. SE REFIERE TAMBIEN A UN COMPOSICION FARMACEUTICA. EL COMPUESTO DE FORMULA I ES UN INHIBIDOR DEL INTERCAMBIADOR DE SODIO-HIDROGENO TIPO 1 (NHE-1) Y ES UTIL PARA ES UTIL PARA REDUCIR LAS LESIONES TISULARES RESULTANTE DE LA ISQUEMIA O HIPOXIA EN DIFERENTES TEJIDOS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20043200P | 2000-04-28 | 2000-04-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20011270A1 true PE20011270A1 (es) | 2001-12-12 |
Family
ID=22741697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2001000376A PE20011270A1 (es) | 2000-04-28 | 2001-04-26 | [5-ciclopropil-1-(2-quinolon-5-il)-1h-pirazol-4-carbonil]guanidina como inhibidor del intercambiador de sodio-hidrogeno de tipo 1 (nhe-1) |
Country Status (40)
Country | Link |
---|---|
EP (1) | EP1276737A1 (es) |
JP (1) | JP2003531900A (es) |
KR (1) | KR20020093079A (es) |
CN (1) | CN1225466C (es) |
AP (1) | AP2002002651A0 (es) |
AR (1) | AR028375A1 (es) |
AU (1) | AU2001235896A1 (es) |
BG (1) | BG107139A (es) |
BR (1) | BR0110268A (es) |
CA (1) | CA2407535A1 (es) |
CO (1) | CO5221125A1 (es) |
CR (1) | CR6797A (es) |
CZ (1) | CZ20023408A3 (es) |
DZ (1) | DZ3310A1 (es) |
EA (1) | EA004882B1 (es) |
EE (1) | EE200200615A (es) |
GT (1) | GT200100064A (es) |
HN (1) | HN2001000042A (es) |
HR (1) | HRP20020851A2 (es) |
HU (1) | HUP0300651A2 (es) |
IL (1) | IL152075A0 (es) |
IS (2) | IS6567A (es) |
MA (1) | MA26897A1 (es) |
MX (1) | MXPA02010600A (es) |
MY (1) | MY133842A (es) |
NO (1) | NO20025132L (es) |
NZ (1) | NZ521348A (es) |
OA (1) | OA12256A (es) |
PA (1) | PA8513301A1 (es) |
PE (1) | PE20011270A1 (es) |
PL (1) | PL357765A1 (es) |
SK (1) | SK14872002A3 (es) |
SV (1) | SV2002000418A (es) |
TN (1) | TNSN01065A1 (es) |
TR (1) | TR200202439T2 (es) |
UA (1) | UA73348C2 (es) |
UY (1) | UY26680A1 (es) |
WO (1) | WO2001083470A1 (es) |
YU (1) | YU79602A (es) |
ZA (1) | ZA200208605B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL156220A0 (en) * | 2001-01-31 | 2003-12-23 | Pfizer Prod Inc | Ethanolates of sodium-hydrogen exchanger type-1 inhibitor |
AU2002337460A1 (en) * | 2001-12-19 | 2003-06-30 | Pfizer Products Inc. | Methods for preparing sodium-hydrogen exchanger type-1 inhibitors |
CA2483927A1 (en) * | 2002-05-02 | 2003-11-13 | Pfizer Products Inc. | Treatment of diabetes and diabetic complications with nhe-1 inhibitors |
FR2840302B1 (fr) * | 2002-06-03 | 2004-07-16 | Aventis Pharma Sa | Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant |
ES2220185B1 (es) * | 2002-07-16 | 2006-04-01 | Consejo Sup. De Investig. Cientificas | Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones. |
US7550480B2 (en) * | 2003-02-14 | 2009-06-23 | Smithkline Beecham Corporation | Compounds |
RU2518741C1 (ru) * | 2013-03-22 | 2014-06-10 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" | СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA003603B1 (ru) * | 1998-02-27 | 2003-06-26 | Пфайзер Продактс Инк. | N-[(замещенное пятичленное ди- или триазадиненасыщенное кольцо) карбонил] гуанидиновые производные для лечения ишемии |
-
2001
- 2001-02-28 AP APAP/P/2002/002651A patent/AP2002002651A0/en unknown
- 2001-02-28 NZ NZ521348A patent/NZ521348A/en unknown
- 2001-02-28 MX MXPA02010600A patent/MXPA02010600A/es active IP Right Grant
- 2001-02-28 JP JP2001580898A patent/JP2003531900A/ja active Pending
- 2001-02-28 AU AU2001235896A patent/AU2001235896A1/en not_active Abandoned
- 2001-02-28 BR BR0110268-0A patent/BR0110268A/pt not_active IP Right Cessation
- 2001-02-28 EE EEP200200615A patent/EE200200615A/xx unknown
- 2001-02-28 TR TR2002/02439T patent/TR200202439T2/xx unknown
- 2001-02-28 IL IL15207501A patent/IL152075A0/xx unknown
- 2001-02-28 WO PCT/IB2001/000277 patent/WO2001083470A1/en not_active Application Discontinuation
- 2001-02-28 CN CNB018087256A patent/CN1225466C/zh not_active Expired - Fee Related
- 2001-02-28 SK SK1487-2002A patent/SK14872002A3/sk unknown
- 2001-02-28 EP EP01908037A patent/EP1276737A1/en not_active Withdrawn
- 2001-02-28 EA EA200201023A patent/EA004882B1/ru not_active IP Right Cessation
- 2001-02-28 PL PL01357765A patent/PL357765A1/xx not_active Application Discontinuation
- 2001-02-28 UA UA2002108497A patent/UA73348C2/uk unknown
- 2001-02-28 DZ DZ013310A patent/DZ3310A1/fr active
- 2001-02-28 HU HU0300651A patent/HUP0300651A2/hu unknown
- 2001-02-28 CA CA002407535A patent/CA2407535A1/en not_active Abandoned
- 2001-02-28 OA OA1200200331A patent/OA12256A/en unknown
- 2001-02-28 KR KR1020027014355A patent/KR20020093079A/ko active IP Right Grant
- 2001-02-28 YU YUP-796/02A patent/YU79602A/sh unknown
- 2001-02-28 CZ CZ20023408A patent/CZ20023408A3/cs unknown
- 2001-03-06 HN HN2001000042A patent/HN2001000042A/es unknown
- 2001-03-12 PA PA20018513301A patent/PA8513301A1/es unknown
- 2001-04-20 GT GT200100064A patent/GT200100064A/es unknown
- 2001-04-24 UY UY26680A patent/UY26680A1/es not_active Application Discontinuation
- 2001-04-26 PE PE2001000376A patent/PE20011270A1/es not_active Application Discontinuation
- 2001-04-26 AR ARP010101970A patent/AR028375A1/es unknown
- 2001-04-26 MY MYPI20011977A patent/MY133842A/en unknown
- 2001-04-27 TN TNTNSN01065A patent/TNSN01065A1/fr unknown
- 2001-04-27 SV SV2001000418A patent/SV2002000418A/es not_active Application Discontinuation
- 2001-04-27 CO CO01032977A patent/CO5221125A1/es not_active Application Discontinuation
-
2002
- 2002-09-23 BG BG107139A patent/BG107139A/bg unknown
- 2002-09-24 IS IS6567A patent/IS6567A/is unknown
- 2002-10-18 CR CR6797A patent/CR6797A/es not_active Application Discontinuation
- 2002-10-18 MA MA26875A patent/MA26897A1/fr unknown
- 2002-10-21 IS IS6588A patent/IS6588A/is unknown
- 2002-10-24 ZA ZA200208605A patent/ZA200208605B/en unknown
- 2002-10-25 HR HR20020851A patent/HRP20020851A2/hr not_active Application Discontinuation
- 2002-10-25 NO NO20025132A patent/NO20025132L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03005464A (es) | Agentes antivirales. | |
IS8502A (is) | Azatvíhringja heteróhringir sem kannabínóíð-viðtakastillar | |
CU23105A3 (es) | DERIVADOS NOVEDOSOS DEL áCIDO AMINODICARBOXILICO CON PROPIEDADES FARMACéUTICAS | |
UY26977A1 (es) | Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti-inflamatorios y analgésicos | |
PA8593001A1 (es) | Derivados de pirimidina para el tratamiento del crecimiento celular anormal | |
SE0202463D0 (sv) | Novel compounds | |
GT200100137A (es) | Pro-drogas de derivados de 4-fenil-piridina. | |
BRPI0313942B8 (pt) | derivados de benzimidazol úteis como agentes antiproliferativos, seus processos de preparação, composição farmacêutica compreendendo os mesmos e usos dos referidos compostos nas preparações de composições farmacêuticas | |
PA8591701A1 (es) | Derivados de pirrolopirimidina | |
ECSP024393A (es) | Derivados biciclicos sustituidos para el tratamiento del crecimiento celular normal | |
MY123310A (en) | Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions | |
AR058180A1 (es) | Indeno derivados, su preparacion y su uso como medicamentos | |
CR7931A (es) | 4-[(2,4-dicloro-5-metroxifenil)amino]-6-alkoxi-3- quinolincarbonitrilos para el tratamiento de lesiones isquemicas | |
UY27872A1 (es) | Inhibidores de caspasa y usos de los mismos. | |
AR036248A1 (es) | Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica | |
PE20010541A1 (es) | Uso de una composicion de benzimidazol para tratar el cancer | |
IL169184A0 (en) | Aromatic compounds as anti-inflammatory, immunomdulatory and anti-proliferatory agents | |
SE0302573D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
PE20011270A1 (es) | [5-ciclopropil-1-(2-quinolon-5-il)-1h-pirazol-4-carbonil]guanidina como inhibidor del intercambiador de sodio-hidrogeno de tipo 1 (nhe-1) | |
UY30847A1 (es) | Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales | |
AR038658A1 (es) | Derivados de 4-aril-2(1h) quinazolinona y 4-aril-quinazolina 2-sustituidas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la preparacion de un medicamento | |
TR200102008T2 (tr) | Serebral işemi profilaksı ve tedavisi için piridin türevlerinin kullanımı. | |
SE0302570D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
BRPI9509819B8 (pt) | benzamida enterocinética e composição farmacêutica compreendendo a mesma | |
AR026022A1 (es) | Metodo para el tratamiento de la obesidad |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |